API |
IMPURITY |
CHEMICAL NAME |
STRUCTURE |
Valsartan |
Valsartan Related Compound C |
(S)-N-valeryl-N-{(2-(1H-tetrazole-5- yl)-biphenyl-4- yl]- methyl}-valine benzyl ester] |  |
Valsartan |
Valsartan Related Compound B |
(S)-N-butyryl-N-{[2’-(1-H-tetrazole-5-yl)-biphenyl-4- yl]-methyl}-valine] |  |
Valsartan |
Valsartan IH impurity |
S]-methyl-2-((2'-cyanobiphenyl-4-yl) ethyl amino)-3-methylbutanoate HCl |  |
Valsartan |
Valsartan IH impurity |
(S)-methyl-2-(N-((2’-Cyano biphenyl -4- yl)methyl) pentanamido)-3- methylbutanoate |  |
Valsartan |
Valsartan IH impurity |
S)-2-((2’-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl amino)-3-methylbutanoic acid |  |
Valsartan |
Valsartan IH impurity |
(S)-methyl 2-((2’-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl amino)-3-methylbutanoate |  |
Valsartan |
Valsartan IH impurity |
(S)-methyl 2-(N-((2’-(1H-tetrazole-5-yl)biphenyl-4-yl)methyl)pentanomido)-3-methylbutanoate |  |
Valsartan |
Valsartan IH impurity |
(S)-2-[N-((2’-cyanobiphenyl-4-yl)Methyl)pentanamido]-3-Methyl butanoic acid | |
Valsartan |
Valsartan Related Compound A |
(R)-N-valeryl-N-([2’-[1H-tetrazole-5-yl] biphenyl-4-yl]-methyl)-valine |  |